Gary Layton

40 papers and 1.9k indexed citations i.

About

Gary Layton is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Gary Layton has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Physiology. Recurrent topics in Gary Layton’s work include HIV/AIDS drug development and treatment (7 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Antifungal resistance and susceptibility (6 papers). Gary Layton is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Antifungal resistance and susceptibility (6 papers). Gary Layton collaborates with scholars based in United Kingdom, United States and Germany. Gary Layton's co-authors include Robyn J. Barst, Rachel Dockry, Bruce G. McCarthy, Anthony Ford, Rayid Abdulqawi, Kimberley Holt, John A. Smith, Tomás Pulido, D. Dunbar Ivy and Marjana Serdarevic-Pehar and has published in prestigious journals such as The Lancet, Circulation and PLoS ONE.

In The Last Decade

Co-authorship network of co-authors of Gary Layton i

Fields of papers citing papers by Gary Layton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Layton. The network helps show where Gary Layton may publish in the future.

Countries citing papers authored by Gary Layton

Since Specialization
Citations

This map shows the geographic impact of Gary Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Layton more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025